Evolving Use of fMRI in Medicare Beneficiaries

References

1. 1.↵
   1. Ogawa S,
   2. Lee TM,
   3. Kay AR, et al

   . Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868–72 doi:10.1073/pnas.87.24.9868 pmid:2124706

   Abstract/FREE Full Text
2. 2.↵
   1. Matthews PM,
   2. Honey GD,
   3. Bullmore ET

   . Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci 2006;7:732–44 doi:10.1038/nrn1929 pmid:16924262

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Hart J Jr.,
   2. Rao SM,
   3. Nuwer M

   . Clinical functional magnetic resonance imaging. Cogn Behav Neurol 2007;20:141–44 doi:10.1097/WNN.0b013e31812570e2 pmid:17846511

   CrossRefPubMed
4. 4.↵
   1. Duszak R Jr.,
   2. Bilal N,
   3. Picus D, et al

   . Central venous access: evolving roles of radiology and other specialties nationally over two decades. J Am Coll Radiology 2013;10:603–12 doi:10.1016/j.jacr.2013.02.002

   CrossRefPubMed
5. 5.↵
   1. Duszak R Jr.,
   2. Walls DG,
   3. Wang JM, et al

   . Expanding roles of nurse practitioners and physician assistants as providers of nonvascular invasive radiology procedures. J Am Coll Radiol 2015;12:284–89 doi:10.1016/j.jacr.2014.08.021 pmid:25444061

   CrossRefPubMed
6. 6.↵
   1. Yousem DM

   . The economics of functional magnetic resonance imaging: clinical and research. Neuroimaging Clin N Am 2014;24:717–24 doi:10.1016/j.nic.2014.07.007 pmid:25441510

   CrossRefPubMed
7. 7.↵
   1. Morris E,
   2. Duszak R Jr.,
   3. Sista AK, et al

   . National trends in inferior vena cava filter placement and retrieval procedures in the Medicare population over two decades. J Am Coll Radiol 2018;15:1080–86 doi:10.1016/j.jacr.2018.04.024 pmid:30028676

   CrossRefPubMed
8. 8.↵
   1. Babiarz LS,
   2. Yousem DM,
   3. Parker L, et al

   . Utilization rates of neuroradiology across neuroscience specialties in the private office setting: who owns or leases the scanners on which studies are performed? AJNR Am J Neuroradiol 2012;33:43–48 doi:10.3174/ajnr.A2738 pmid:22033720

   Abstract/FREE Full Text
9. 9.↵
   1. Garcia CR,
   2. Slone SA,
   3. Dolecek TA, et al

   . Primary central nervous system tumor treatment and survival in the United States, 2004–2015. J Neurooncol 2019;144:179–91 doi:10.1007/s11060-019-03218-8 pmid:31254264

   CrossRefPubMed
10. 10.↵
    1. Al-Okaili RN,
    2. Krejza J,
    3. Wang S, et al

    . Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults Radiographics 2006;2(Suppl 1):S173–89 pmid:17050514

    PubMed
11. 11.↵
    1. Brodbelt A

    . Clinical applications of imaging biomarkers, Part 2: the neurosurgeon’s perspective. Br J Radiol 2011;84(Spec No 2):S205–08 doi:10.1259/bjr/19282704 pmid:22433829

    Abstract/FREE Full Text
12. 12.↵
    1. Mabray MC,
    2. Barajas RF Jr.,
    3. Cha S

    . Modern brain tumor imaging. Brain Tumor Res Treat 2015;3:8–23 doi:10.14791/btrt.2015.3.1.8 pmid:25977902

    CrossRefPubMed
13. 13.↵
    1. Feigin VL,
    2. Abajobir AA,
    3. Abate KH, et al

    . Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017;16:877–97 doi:10.1016/S1474-4422(17)30299-5 pmid:28931491

    CrossRefPubMed
14. 14.↵
    1. Sanai N,
    2. Berger MS

    . Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753–64; discussion 264-66 doi:10.1227/01.neu.0000318159.21731.cf pmid:18496181

    CrossRefPubMedWeb of Science
15. 15.↵
    Center for Medicare & Medicaid Services. Medicare Physician Fee Schedule (MPFS). https://www.cms.gov/apps/physician-fee-schedule/overview.aspx. Accessed June 10, 2020
16. 16.↵
    1. Bagic A,
    2. Funke ME,
    3. Ebersole J

    ; ACMEGS Position Statement Committee. American Clinical MEG Society (ACMEGS) position statement: the value of magnetoencephalography (MEG)/magnetic source imaging (MSI) in noninvasive presurgical evaluation of patients with medically intractable localization-related epilepsy. J Clin Neurophysiol 2009;26:290–93 doi:10.1097/WNP.0b013e3181b49d50 pmid:19602984

    CrossRefPubMed
17. 17.↵
    1. RamachandranNair R,
    2. Otsubo H,
    3. Shroff MM, et al

    . MEG predicts outcome following surgery for intractable epilepsy in children with normal or nonfocal MRI findings. Epilepsia 2007;48:149–57 doi:10.1111/j.1528-1167.2006.00901.x pmid:17241222

    CrossRefPubMed
18. 18.↵
    1. Knowlton RC,
    2. Shih J

    . Magnetoencephalography in epilepsy. Epilepsia 2004;45(Suppl 4):61–71 doi:10.1111/j.0013-9580.2004.04012.x pmid:15281961

    CrossRefPubMed
19. 19.↵
    American Clinical MEG Society. Clinical MEG Locations. https://www.acmegs.org/membership/clinical-meg-locations. Accessed June 9, 2020
20. 20.↵
    1. Greicius MD,
    2. Srivastava G,
    3. Reiss AL, et al

    . Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637–42 doi:10.1073/pnas.0308627101 pmid:15070770

    Abstract/FREE Full Text
21. 21.↵
    1. Lee MH,
    2. Smyser CD,
    3. Shimony JS

    . Resting-state fMRI: a review of methods and clinical applications. AJNR Am J Neuroradiol 2013;34:1866–72 doi:10.3174/ajnr.A3263 pmid:22936095

    Abstract/FREE Full Text
22. 22.↵
    1. Lee MH,
    2. Miller-Thomas MM,
    3. Benzinger TL, et al

    . Clinical resting-state fMRI in the preoperative setting: are we ready for prime time? Top Magn Reson Imaging 2016;25:11–18 doi:10.1097/RMR.0000000000000075 pmid:26848556

    CrossRefPubMed
23. 23.↵
    1. Greicius M

    . Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol 2008;21:424–30 doi:10.1097/WCO.0b013e328306f2c5 pmid:18607202

    CrossRefPubMedWeb of Science
24. 24.↵
    National Cancer Institute. Cancer Stat Facts: Brain and Other Nervous System Cancer. https://seer.cancer.gov/statfacts/html/brain.html. Accessed January 20, 2020